<SEC-DOCUMENT>0001006837-25-000002.txt : 20250121
<SEC-HEADER>0001006837-25-000002.hdr.sgml : 20250121
<ACCEPTANCE-DATETIME>20250121080137
ACCESSION NUMBER:		0001006837-25-000002
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250117
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250121
DATE AS OF CHANGE:		20250121

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INNOVATE Corp.
		CENTRAL INDEX KEY:			0001006837
		STANDARD INDUSTRIAL CLASSIFICATION:	FABRICATED STRUCTURAL METAL PRODUCTS [3440]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				541708481
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35210
		FILM NUMBER:		25540473

	BUSINESS ADDRESS:	
		STREET 1:		295 MADISON AVENUE
		STREET 2:		12TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		19546631147

	MAIL ADDRESS:	
		STREET 1:		295 MADISON AVENUE
		STREET 2:		12TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HC2 HOLDINGS, INC.
		DATE OF NAME CHANGE:	20160809

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HC2 Holdings, Inc.
		DATE OF NAME CHANGE:	20140415

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PTGi HOLDING, INC.
		DATE OF NAME CHANGE:	20131108
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>hchc-20250117.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:d550d92f-a220-41b2-b97e-083f7fb88261,g:09f60888-d082-4863-aa78-05ddc8c4bab0,d:c866be9313044788a85b3ff6b417b457-->
<html xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:hchc="http://hc2.com/20250117" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hchc-20250117</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-25">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-26">0001006837</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="dei:NoTradingSymbolFlag" format="ixt:fixed-true" id="f-27">TRUE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hchc-20250117.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001006837</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-17</xbrli:startDate><xbrli:endDate>2025-01-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001006837</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hchc:CommonStockParValue0001PerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-17</xbrli:startDate><xbrli:endDate>2025-01-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001006837</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hchc:PreferredStockPurchaseRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-17</xbrli:startDate><xbrli:endDate>2025-01-17</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ic866be9313044788a85b3ff6b417b457_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">UNITED STATES</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date of Report (Date of Earliest Event Reported):</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">January 17, 2025</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">INNOVATE CORP.</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.744%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.064%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.892%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-35210</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">54-1708481</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.071%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">295 Madison Ave</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">12th Fl</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">New York</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-10">NY</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">10017</ix:nonNumeric></ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.142%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registrant&#8217;s telephone number, including area code:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">212</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">235-2691</ix:nonNumeric></span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Former name or former address, if changed since last report</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:3.152%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.648%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;<ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;<ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;<ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-17">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;<ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-18">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.252%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:Security12bTitle" id="f-19">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:TradingSymbol" id="f-20">VATE</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-21">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-3" name="dei:Security12bTitle" id="f-22">Preferred Stock Purchase Rights</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-23">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.413%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:70.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-24">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:95.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#9744;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:481.50pt"><tr><td style="width:1.0pt"/><td style="width:54.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:423.25pt"/><td style="width:1.0pt"/></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Item 8.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Other Events</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On January 17, 2025, INNOVATE Corp. issued a press release announcing that the U.S. Food and Drug Administration has approved the MediBeacon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Transdermal GFR for the assessment of kidney function in patients with normal or impaired renal function. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The information contained in this Current Report on Form 8-K, including the exhibit attached hereto, is being furnished and shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;), or incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, unless such subsequent filing specifically references this Form 8-K.</span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:481.50pt"><tr><td style="width:1.0pt"/><td style="width:54.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:423.25pt"/><td style="width:1.0pt"/></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Item 9.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Financial Statements and Exhibits.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(d)&#160;&#160;&#160;&#160;Exhibits</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.610%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit No.&#160;&#160;</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;Description</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline" href="a202410258-kxexhibit991.htm">Press Release dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline" href="a202410258-kxexhibit991.htm">January </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline" href="a202410258-kxexhibit991.htm">17</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline" href="a202410258-kxexhibit991.htm">, 2025</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline" href="a202410258-kxexhibit991.htm">, titled &#8220;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline" href="a202410258-kxexhibit991.htm">MediBeacon</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;text-decoration:underline;top:-4.2pt;vertical-align:baseline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;text-decoration:underline;top:-4.2pt;vertical-align:baseline" href="a202410258-kxexhibit991.htm">&#174;</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline" href="a202410258-kxexhibit991.htm"> Transdermal GFR Receives FDA Approval to Assess Kidney Function&#8221;</a></span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">SIGNATURES</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date: January 21, 2025</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.857%"><tr><td style="width:1.0%"/><td style="width:47.137%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.877%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INNOVATE Corp.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Registrant)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By:</span></td><td colspan="12" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">/s/ Michael J. Sena</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name: Michael J. Sena</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title: Chief Financial Officer</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a202410258-kxexhibit991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i848f2b9b1d7d4a4986b5518d29f5f6e5_1"></div><div style="min-height:36pt;width:100%"><div><img alt="image_1a.jpg" src="image_1a.jpg" style="height:58px;margin-bottom:5pt;vertical-align:text-bottom;width:211px"></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">MediBeacon&#174; Transdermal GFR System Receives FDA Approval to Assess Kidney Function</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:12.53pt">Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:13.52pt">The transdermal GFR (tGFR) methodology has been designed to be effective across the adult population without input of age, weight, sex, gender, race, or ethnicity.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:13.52pt">More than 800 million people have Chronic Kidney Disease (CKD), one of the world&#8217;s leading causes of mortality worldwide, with associated deaths increasing over the past two decades</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NEW YORK, January 17, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE&#58; VATE) (&#8220;INNOVATE&#8221; or the &#8220;Company&#8221;) announced today that the U.S. Food and Drug Administration (FDA) has approved the MediBeacon&#174; TGFR for the assessment of kidney function in patients with normal or impaired renal function.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The TGFR is comprised of the TGFR Sensor, TGFR Monitor, and Lumitrace&#174; (relmapirazin) injection, a non-radioactive, non-iodinated fluorescent GFR tracer agent, which together allow assessment of kidney function by measuring the clearance rate of the fluorescent agent as it leaves the body. The system records Lumitrace fluorescence intensity transdermally as a function of time via a sensor placed on the skin. The TGFR Sensor records 2.5 fluorescent readings per second and the TGFR Monitor will display the average session tGFR reading at the patient&#8217;s bedside or in the outpatient setting. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The TGFR is validated for use in the assessment of Glomerular Filtration Rate (GFR) in patients with stable kidney function at the point of care. The TGFR utilizes an intravenous Lumitrace injection but does not require blood draws or urine analysis, unlike current methodologies requiring multiple blood draws or urine samples. In addition, current clinical practice measured GFR (mGFR) assessment requires sophisticated clinical laboratory analysis away from the patient&#8217;s point of care.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;The development of a system such as the TGFR that assesses a patient&#8217;s kidney function without the need to use estimating equations is an important milestone for the nephrology community,&#8221; said Dr. Mitchell Rosner, chair of the Department of Medicine at University of Virginia and a highly regarded expert who has authored numerous articles on the challenges of assessing kidney function. &#8220;We are excited to explore applications of the transdermal GFR methodology in patients where current clinical practice is understood to be suboptimal.&#8221; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dr. Pierre Galichon, an active kidney researcher at the Sorbonne Universit&#233; and an attending physician in kidney transplantation at Piti&#233;-Salp&#234;tri&#232;re Hospital in Paris, said&#58; &#8220;It has long been a challenge to understand kidney function in the context of its interaction with other vital organs such as the heart and lungs. My experience with MediBeacon products in preclinical use, as relayed in Scientific Reports,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> has been exciting, and I look forward to evaluating how transdermal GFR can be applied in clinical practice.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;The approval of the TGFR by the FDA demonstrates our proprietary system can provide an effective option for assessing kidney function,&#8221; said Steve Hanley, CEO of MediBeacon. &#8220;According to the National Kidney Foundation, CKD causes more deaths each year than breast cancer or prostate cancer. It is the under-recognized public health crisis.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The potential applications for the TGFR are numerous, and we look forward to exploring them with clinicians both in the hospital and outpatient settings.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The timing of FDA approval aligns well with the Q4 2024 publication by MediBeacon&#8217;s Chief Scientific Officer, Dr. Richard Dorshow, et al in Kidney International with data that supports the utility of MediBeacon&#8217;s patented agent Lumitrace&#174;.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The TGFR met its primary efficacy endpoint as per agreement with the FDA by demonstrating a P30 value of 94% while recruiting patients with a range of GFR values and skin tones. P30 is defined as the percentage of GFR estimation falling within +&#47;- 30% of measured GFR (mGFR) values.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt;padding-left:19.25pt;padding-right:19.25pt;text-align:center"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">P30 Value</font></div></td><td colspan="3" style="background-color:#000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt;padding-left:7.75pt;padding-right:7.75pt;text-align:center;text-indent:-31.65pt"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Upper 95%</font></div><div style="margin-top:0.05pt;padding-left:32.2pt;padding-right:32.2pt;text-align:center"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#160;Con&#64257;dence Bounds</font></div></td><td colspan="3" style="background-color:#000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt;padding-left:7.77pt;padding-right:7.77pt;text-align:center;text-indent:-31.5pt"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Lower 95% </font></div><div style="margin-top:0.05pt;padding-left:32.22pt;padding-right:32.22pt;text-align:center"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Con&#64257;dence Bounds</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:45.65pt;padding-right:45.65pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:12.35pt">94.0%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:49.1pt;padding-right:49.1pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:12.35pt">96.9%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:49.07pt;padding-right:49.07pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:12.35pt">89.4%</font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In clinical studies no serious or severe adverse events have been observed. For more information, including the FDA Summary of Safety and Effectiveness Data, please refer to www.fda.gov.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About INNOVATE<br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">INNOVATE Corp.&#160;is a portfolio of best-in-class assets in three key areas of the new economy &#8211; Infrastructure, Life Sciences and Spectrum. Dedicated to stakeholder capitalism, INNOVATE employs approximately 4,000 people across its subsidiaries. For more information, please visit&#58;&#160;</font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.INNOVATECorp.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About MediBeacon Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MediBeacon is a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection. MediBeacon&#8217;s use of proprietary fluorescent tracer agents coupled with transdermal detection technology focuses on providing vital and actionable measurement of organ function. MediBeacon owns over 55 granted U.S. patents and over 215 granted patents worldwide that provide extensive coverage of the MediBeacon&#174; TGFR, including Lumitrace&#174; injection, the sensor and algorithms, as well as other strategic uses of its proprietary pyrazine platform and sensor technology. The TGFR is approved for human use. Potential technology applications in gastroenterology, ophthalmology and surgery are in various stages of clinical development. MediBeacon is based in St. Louis, Missouri, with additional operations in Mannheim, Germany. For more information, please visit&#58;  www.medibeacon.com</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Lumitrace&#174; (relmapirazin) injection</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Relmapirazin is a non-radioactive, non-iodinated pyrazine-based compound, which has been engineered to be inert, highly fluorescent and have the clearance properties of a GFR tracer agent in the body. Lumitrace injection has been administered to over 850 subjects under Investigational Device Exemptions (IDEs). The unique photophysical characteristics of Lumitrace have been designed to enable the collection of fluorescence data via a photodetector sensor placed on the skin. Data collected by the sensor measures the change in the intensity of Lumitrace fluorescence over time and is converted into a transdermal GFR (tGFR) by proprietary algorithms. As noted above, in a phase 2 investigational study mGFR deduced from Lumitrace matched that of mGFR deduced from iohexol over a range of GFR values. See the peer reviewed article published in the October 2024 issue of Kidney International</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> by Dorshow et al.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Certain statements in this press release may constitute &#8220;forward-looking statements&#8221; within the meaning of the federal securities laws. Forward-looking statements generally relate to future events, such as the expected timing of the reverse stock split, the impact of the reverse stock split on the Company&#8217;s share price, and the Company&#8217;s ability to meet the minimum per share bid price requirement for continued listing on the NYSE. You are cautioned that such statements are not guarantees of future performance and that INNOVATE&#8217;s actual results may differ materially from those set forth in the forward-looking statements. All of these forward-looking statements are subject to risks and uncertainties that may change at any time. Factors that could cause INNOVATE&#8217;s actual expectations to differ materially from these forward-looking statements include INNOVATE&#8217;s ability to continue to comply with applicable listing standards of the NYSE and the other factors under the heading &#8220;Risk Factors&#8221; set forth in INNOVATE&#8217;s Annual Report on Form 10-K, as supplemented by INNOVATE&#8217;s </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">quarterly reports on Form 10-Q. Such filings are available on our website or at www.sec.gov. You should not place undue reliance on these forward-looking statements, which are made only as of the date of this press release. INNOVATE undertakes no obligation to publicly update or revise forward-looking statements to reflect subsequent developments, events, or circumstances, except as may be required under applicable securities laws.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Investor Contact&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Solebury Strategic Communications</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Anthony Rozmus</font></div><div style="text-align:justify"><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ir&#64;innovatecorp.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(212) 235-2691</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IMPORTANT SAFETY INFORMATION FOR TGFR </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Indication for Use&#58;</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The MediBeacon&#174; Transdermal GFR System (TGFR) is intended to assess the Glomerular Filtration Rate (GFR) in adult patients with impaired or normal renal function by noninvasively monitoring fluorescent light emission from an exogenous tracer agent over time. The MediBeacon TGFR consists of a monitor and a sensor, which are to be used with the Lumitrace&#174; tracer only. This device has been validated in patients with stable renal function.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The MediBeacon TGFR is not approved for use in patients with GFR &#60;15ml&#47;min&#47;1.73m2, GFR &#62;120ml&#47;min&#47;1.73m2, patients on dialysis or anuric patients. The use of this device in patients with dynamic and rapidly changing renal function has not been validated. This device is not intended to diagnose acute kidney injury (AKI).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Contraindications</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;  There are no known contraindications.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Warnings and Precautions&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">See </font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ifu.medibeacon.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> for full instructions, warnings, and cautions.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">In clinical studies no serious or severe adverse events have been observed.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Lumitrace</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> injection has light absorbance at 266nm and 435nm, and broad fluorescent emission at &#126;560nm when excited at &#126;440nm. Any drug activated at these wavelengths should not be used in conjunction with Lumitrace.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Lumitrace injection may interfere with clinical laboratory tests. DO NOT ADMINISTER if the patient is expected to need clinical laboratory testing while Lumitrace is present in their system (up to 72 hours for renally-impaired patients). The presence of Lumitrace decreased B-Type Natriuretic Peptide (BNP) results by around 20% in limited testing.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Bolus infusions may impact the GFR assessment temporarily while the vasculature-tissue equilibrium is re-established.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">During a TGFR session, the patient should be as still as possible, especially during the &#8220;Establishing Baseline&#8221; stage. The current system is designed to compensate for light activity such as reading or eating after the Baseline stage.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Epidemiology of chronic kidney disease&#58; an update 2022, Kidney International Supplement, 2022 Apr&#59;12(1)&#58;7-11.</font><font style="color:#0563c1;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"> </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">doi&#58; 10.1016&#47;j.kisu.2021.11.003</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">., Csaba P Kovesdy</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Pulmonary hypertension without heart failure causes cardiorenal syndrome in a porcine model, Scientific Reports (2023) 13&#58;9130, Orieux et al, </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">doi.org&#47;10.1038&#47;s41598-023-36124-1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> National Kidney Foundation, Fast Facts (2024 Update), Updated as of 8&#47;6&#47;2024</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Clinical validation of the novel fluorescent glomerular filtration rate tracer agent relmapirazin (MB-102), Kidney International, Volume 106, Issue 4, P679-687, October 2024, DOI&#58; </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">10.1016&#47;j.kint.2024.06.012</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>hchc-20250117.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:d550d92f-a220-41b2-b97e-083f7fb88261,g:09f60888-d082-4863-aa78-05ddc8c4bab0-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hchc="http://hc2.com/20250117" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://hc2.com/20250117">
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hchc-20250117_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hchc-20250117_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hchc-20250117_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://hc2.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="hchc_CommonStockParValue0001PerShareMember" abstract="true" name="CommonStockParValue0001PerShareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hchc_PreferredStockPurchaseRightsMember" abstract="true" name="PreferredStockPurchaseRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>hchc-20250117_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:d550d92f-a220-41b2-b97e-083f7fb88261,g:09f60888-d082-4863-aa78-05ddc8c4bab0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://hc2.com/role/Cover" xlink:type="simple" xlink:href="hchc-20250117.xsd#Cover"/>
  <link:definitionLink xlink:role="http://hc2.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_4a9308e6-0245-46b3-a4cd-477c6585578c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_DocumentInformationTable_4a9308e6-0245-46b3-a4cd-477c6585578c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_69c58908-25ef-40df-878c-47924f783fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_4a9308e6-0245-46b3-a4cd-477c6585578c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_69c58908-25ef-40df-878c-47924f783fd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_69c58908-25ef-40df-878c-47924f783fd6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_69c58908-25ef-40df-878c-47924f783fd6" xlink:to="loc_us-gaap_ClassOfStockDomain_69c58908-25ef-40df-878c-47924f783fd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b208b496-bf1b-463e-b190-c44660aaa9de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_69c58908-25ef-40df-878c-47924f783fd6" xlink:to="loc_us-gaap_ClassOfStockDomain_b208b496-bf1b-463e-b190-c44660aaa9de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hchc_CommonStockParValue0001PerShareMember_a05156df-2c95-404c-9dc0-d86c6af463b7" xlink:href="hchc-20250117.xsd#hchc_CommonStockParValue0001PerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b208b496-bf1b-463e-b190-c44660aaa9de" xlink:to="loc_hchc_CommonStockParValue0001PerShareMember_a05156df-2c95-404c-9dc0-d86c6af463b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hchc_PreferredStockPurchaseRightsMember_817ed920-9221-4fe2-a0fa-67a0eab03f28" xlink:href="hchc-20250117.xsd#hchc_PreferredStockPurchaseRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b208b496-bf1b-463e-b190-c44660aaa9de" xlink:to="loc_hchc_PreferredStockPurchaseRightsMember_817ed920-9221-4fe2-a0fa-67a0eab03f28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ae6e79f7-e5a6-4c0e-a4ec-53b924c6d8c8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_DocumentType_ae6e79f7-e5a6-4c0e-a4ec-53b924c6d8c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_12cb1052-e54c-4fc5-b7a4-e96a1002ddc2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_DocumentPeriodEndDate_12cb1052-e54c-4fc5-b7a4-e96a1002ddc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_cc3d4f94-d003-4fc4-81b8-2248e41fb787" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityRegistrantName_cc3d4f94-d003-4fc4-81b8-2248e41fb787" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f57adba9-7a51-4f56-8883-bc6a9bf84edc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f57adba9-7a51-4f56-8883-bc6a9bf84edc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ed9d8b35-5642-4f7b-b78c-9ab044a2ff11" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityFileNumber_ed9d8b35-5642-4f7b-b78c-9ab044a2ff11" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_67675205-3e51-4fb4-a42e-fc913bf7cf60" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityTaxIdentificationNumber_67675205-3e51-4fb4-a42e-fc913bf7cf60" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_694ecbc6-05cb-4fb4-81a8-950876736f3c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityAddressAddressLine1_694ecbc6-05cb-4fb4-81a8-950876736f3c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_cbddc4a0-2a5d-4a65-bdda-43cbbe953dc0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityAddressAddressLine2_cbddc4a0-2a5d-4a65-bdda-43cbbe953dc0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_8eddb7da-291e-4b24-ac87-d3f307b98df8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityAddressCityOrTown_8eddb7da-291e-4b24-ac87-d3f307b98df8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_45551630-bb12-47b7-b5bf-7f3899a9cb1f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityAddressStateOrProvince_45551630-bb12-47b7-b5bf-7f3899a9cb1f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e9733a11-4afe-4b9c-8448-d410405f700a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityAddressPostalZipCode_e9733a11-4afe-4b9c-8448-d410405f700a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d0db173e-ccc1-485e-bca0-8eafd4418a5a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_CityAreaCode_d0db173e-ccc1-485e-bca0-8eafd4418a5a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_c0eefc7d-0dc3-4405-9861-cf60f7d548de" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_LocalPhoneNumber_c0eefc7d-0dc3-4405-9861-cf60f7d548de" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_8b323cec-f4da-43cc-a63e-e518ab6c0205" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_WrittenCommunications_8b323cec-f4da-43cc-a63e-e518ab6c0205" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_dce3cb01-3fe2-416f-ad27-46120ff25a7a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_SolicitingMaterial_dce3cb01-3fe2-416f-ad27-46120ff25a7a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_6d7495c4-dc0c-4f6f-95a7-fc56bc7fd2c5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_PreCommencementTenderOffer_6d7495c4-dc0c-4f6f-95a7-fc56bc7fd2c5" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_83fceba2-89a5-476f-b92e-3c6199a1522b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_83fceba2-89a5-476f-b92e-3c6199a1522b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_daf6e072-7fb9-4d31-9027-79c403328b8d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_Security12bTitle_daf6e072-7fb9-4d31-9027-79c403328b8d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_6386fc6d-b355-43df-866c-a0dc91733944" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_TradingSymbol_6386fc6d-b355-43df-866c-a0dc91733944" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_cd4fd199-a6e9-468c-8e1a-ecdbafe0fae9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_SecurityExchangeName_cd4fd199-a6e9-468c-8e1a-ecdbafe0fae9" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_bd4932a6-d690-4f1c-8506-bbc09c50d386" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityEmergingGrowthCompany_bd4932a6-d690-4f1c-8506-bbc09c50d386" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_cc4aa268-a3d8-4cc4-b66c-9e4c231e3560" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_AmendmentFlag_cc4aa268-a3d8-4cc4-b66c-9e4c231e3560" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7f71263c-0c2a-4cd3-b805-bcf3282f528c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityCentralIndexKey_7f71263c-0c2a-4cd3-b805-bcf3282f528c" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag_57124991-4c54-4df9-a424-11fdc6a1790a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_NoTradingSymbolFlag_57124991-4c54-4df9-a424-11fdc6a1790a" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_e48a10ee-a8a1-4baa-b393-b1592e2ab31c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_CurrentFiscalYearEndDate_e48a10ee-a8a1-4baa-b393-b1592e2ab31c" xlink:type="arc" order="24"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>hchc-20250117_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:d550d92f-a220-41b2-b97e-083f7fb88261,g:09f60888-d082-4863-aa78-05ddc8c4bab0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ClassOfStockDomain_6f3078d2-d99f-4246-859a-4c6442baa226_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_3f18e1cb-69e9-4a40-8e83-3ecfda05feaf_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_22833405-67e1-4c19-9f0e-0936a18360af_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_26f7d7f9-7901-44b8-aef1-880969bc4f6d_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_NoTradingSymbolFlag_5d9de0ff-3d70-4cc2-b623-ed2c9c30bb86_terseLabel_en-US" xlink:label="lab_dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">No Trading Symbol Flag</link:label>
    <link:label id="lab_dei_NoTradingSymbolFlag_label_en-US" xlink:label="lab_dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">No Trading Symbol Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_NoTradingSymbolFlag" xlink:to="lab_dei_NoTradingSymbolFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_77cc55dc-afea-4529-92e6-3e90bf49cc4a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_ba4690e0-5792-4666-a861-1dbce107c3f1_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_17e276dd-4fec-472a-9ee5-62f031b8d548_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_7692585b-cd9e-4302-b879-ce26a9badfc4_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_aac62602-6351-456a-9c6c-370047006b73_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_2e85f4bd-14bb-4eb2-b14c-e583747b0c4e_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_70163588-b481-48b7-b06e-ecb843fb7efc_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_96759f80-2300-42c1-90de-b6ea4327d7f9_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_6db57b13-2820-43f4-b561-da8763dc3c9d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_f01ad432-eee3-44d2-b788-ebd27f7c936b_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_e24f3a0c-bbe0-45b5-b511-6c2f56bf52ec_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_430cc8ca-8dfa-4d44-aace-4885ac42845c_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_e492ab49-2ad4-478b-835c-5164647068cf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_hchc_PreferredStockPurchaseRightsMember_196951f8-06b6-468e-a5a0-47cafb45747b_terseLabel_en-US" xlink:label="lab_hchc_PreferredStockPurchaseRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock Purchase Rights</link:label>
    <link:label id="lab_hchc_PreferredStockPurchaseRightsMember_label_en-US" xlink:label="lab_hchc_PreferredStockPurchaseRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock Purchase Rights [Member]</link:label>
    <link:label id="lab_hchc_PreferredStockPurchaseRightsMember_documentation_en-US" xlink:label="lab_hchc_PreferredStockPurchaseRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Preferred Stock Purchase Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hchc_PreferredStockPurchaseRightsMember" xlink:href="hchc-20250117.xsd#hchc_PreferredStockPurchaseRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hchc_PreferredStockPurchaseRightsMember" xlink:to="lab_hchc_PreferredStockPurchaseRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_8838cd12-f378-441b-a28c-e8de89113520_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_f6ffc24c-6a2d-440e-955c-a20942e9b372_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_a160d73d-fe85-4ffa-a4c7-e14f55b93cf1_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_fcd3c08e-4a33-4ed0-9c7a-eb9c429e393c_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_f81c75ba-f4d0-40a2-abd5-7c4101685fdc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_8ee370cb-0123-44e7-ac20-b1ae72b01921_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_5fc02912-c8a3-4a9f-80e7-8f32ba9c4b00_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_5ceb480c-3399-490e-8c0d-6ecc76b911eb_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_hchc_CommonStockParValue0001PerShareMember_1debe0cb-c4ef-4ed2-bf8c-30abb8ac1ac8_terseLabel_en-US" xlink:label="lab_hchc_CommonStockParValue0001PerShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock, par value $0.001 per share</link:label>
    <link:label id="lab_hchc_CommonStockParValue0001PerShareMember_label_en-US" xlink:label="lab_hchc_CommonStockParValue0001PerShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, par value $0.001 per share [Member]</link:label>
    <link:label id="lab_hchc_CommonStockParValue0001PerShareMember_documentation_en-US" xlink:label="lab_hchc_CommonStockParValue0001PerShareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, par value $0.001 per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hchc_CommonStockParValue0001PerShareMember" xlink:href="hchc-20250117.xsd#hchc_CommonStockParValue0001PerShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hchc_CommonStockParValue0001PerShareMember" xlink:to="lab_hchc_CommonStockParValue0001PerShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_f5b7dece-9e78-4ca6-8627-1fd9c3632986_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_b5eedbc2-7930-4008-a8c3-4c5971419ea5_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_23f7e056-2a8f-41ee-ba95-867790eb1e2e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>hchc-20250117_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:d550d92f-a220-41b2-b97e-083f7fb88261,g:09f60888-d082-4863-aa78-05ddc8c4bab0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://hc2.com/role/Cover" xlink:type="simple" xlink:href="hchc-20250117.xsd#Cover"/>
  <link:presentationLink xlink:role="http://hc2.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_9170c258-9180-4970-b1e0-de529b8225f6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_4a9308e6-0245-46b3-a4cd-477c6585578c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9170c258-9180-4970-b1e0-de529b8225f6" xlink:to="loc_dei_DocumentInformationTable_4a9308e6-0245-46b3-a4cd-477c6585578c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_69c58908-25ef-40df-878c-47924f783fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_4a9308e6-0245-46b3-a4cd-477c6585578c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_69c58908-25ef-40df-878c-47924f783fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b208b496-bf1b-463e-b190-c44660aaa9de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_69c58908-25ef-40df-878c-47924f783fd6" xlink:to="loc_us-gaap_ClassOfStockDomain_b208b496-bf1b-463e-b190-c44660aaa9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hchc_CommonStockParValue0001PerShareMember_a05156df-2c95-404c-9dc0-d86c6af463b7" xlink:href="hchc-20250117.xsd#hchc_CommonStockParValue0001PerShareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b208b496-bf1b-463e-b190-c44660aaa9de" xlink:to="loc_hchc_CommonStockParValue0001PerShareMember_a05156df-2c95-404c-9dc0-d86c6af463b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hchc_PreferredStockPurchaseRightsMember_817ed920-9221-4fe2-a0fa-67a0eab03f28" xlink:href="hchc-20250117.xsd#hchc_PreferredStockPurchaseRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b208b496-bf1b-463e-b190-c44660aaa9de" xlink:to="loc_hchc_PreferredStockPurchaseRightsMember_817ed920-9221-4fe2-a0fa-67a0eab03f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_4a9308e6-0245-46b3-a4cd-477c6585578c" xlink:to="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ae6e79f7-e5a6-4c0e-a4ec-53b924c6d8c8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_DocumentType_ae6e79f7-e5a6-4c0e-a4ec-53b924c6d8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_12cb1052-e54c-4fc5-b7a4-e96a1002ddc2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_DocumentPeriodEndDate_12cb1052-e54c-4fc5-b7a4-e96a1002ddc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_cc3d4f94-d003-4fc4-81b8-2248e41fb787" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityRegistrantName_cc3d4f94-d003-4fc4-81b8-2248e41fb787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f57adba9-7a51-4f56-8883-bc6a9bf84edc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f57adba9-7a51-4f56-8883-bc6a9bf84edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ed9d8b35-5642-4f7b-b78c-9ab044a2ff11" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityFileNumber_ed9d8b35-5642-4f7b-b78c-9ab044a2ff11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_67675205-3e51-4fb4-a42e-fc913bf7cf60" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityTaxIdentificationNumber_67675205-3e51-4fb4-a42e-fc913bf7cf60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_694ecbc6-05cb-4fb4-81a8-950876736f3c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityAddressAddressLine1_694ecbc6-05cb-4fb4-81a8-950876736f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_cbddc4a0-2a5d-4a65-bdda-43cbbe953dc0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityAddressAddressLine2_cbddc4a0-2a5d-4a65-bdda-43cbbe953dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_8eddb7da-291e-4b24-ac87-d3f307b98df8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityAddressCityOrTown_8eddb7da-291e-4b24-ac87-d3f307b98df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_45551630-bb12-47b7-b5bf-7f3899a9cb1f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityAddressStateOrProvince_45551630-bb12-47b7-b5bf-7f3899a9cb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e9733a11-4afe-4b9c-8448-d410405f700a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityAddressPostalZipCode_e9733a11-4afe-4b9c-8448-d410405f700a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d0db173e-ccc1-485e-bca0-8eafd4418a5a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_CityAreaCode_d0db173e-ccc1-485e-bca0-8eafd4418a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_c0eefc7d-0dc3-4405-9861-cf60f7d548de" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_LocalPhoneNumber_c0eefc7d-0dc3-4405-9861-cf60f7d548de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_8b323cec-f4da-43cc-a63e-e518ab6c0205" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_WrittenCommunications_8b323cec-f4da-43cc-a63e-e518ab6c0205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_dce3cb01-3fe2-416f-ad27-46120ff25a7a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_SolicitingMaterial_dce3cb01-3fe2-416f-ad27-46120ff25a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_6d7495c4-dc0c-4f6f-95a7-fc56bc7fd2c5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_PreCommencementTenderOffer_6d7495c4-dc0c-4f6f-95a7-fc56bc7fd2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_83fceba2-89a5-476f-b92e-3c6199a1522b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_83fceba2-89a5-476f-b92e-3c6199a1522b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_daf6e072-7fb9-4d31-9027-79c403328b8d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_Security12bTitle_daf6e072-7fb9-4d31-9027-79c403328b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_6386fc6d-b355-43df-866c-a0dc91733944" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_TradingSymbol_6386fc6d-b355-43df-866c-a0dc91733944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_cd4fd199-a6e9-468c-8e1a-ecdbafe0fae9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_SecurityExchangeName_cd4fd199-a6e9-468c-8e1a-ecdbafe0fae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_bd4932a6-d690-4f1c-8506-bbc09c50d386" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityEmergingGrowthCompany_bd4932a6-d690-4f1c-8506-bbc09c50d386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_cc4aa268-a3d8-4cc4-b66c-9e4c231e3560" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_AmendmentFlag_cc4aa268-a3d8-4cc4-b66c-9e4c231e3560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7f71263c-0c2a-4cd3-b805-bcf3282f528c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_EntityCentralIndexKey_7f71263c-0c2a-4cd3-b805-bcf3282f528c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag_57124991-4c54-4df9-a424-11fdc6a1790a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_NoTradingSymbolFlag_57124991-4c54-4df9-a424-11fdc6a1790a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_e48a10ee-a8a1-4baa-b393-b1592e2ab31c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_19977b4d-5194-46df-9f2c-29ec597bd974" xlink:to="loc_dei_CurrentFiscalYearEndDate_e48a10ee-a8a1-4baa-b393-b1592e2ab31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_1a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_1a.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1"  H )(# 2(  A$! Q$!_\0
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M@Y7I0J3C!WO>*DU%W6^EM>NYZM17E-W^VW^S%I_[64'[#VI?%""V^)UWH?\
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M\%2OV%_!G[7=M^PIXD^-\=O\3[N_M;&'P_\ V+>LGVFXA2:&$W*PFW5W21,
MR Y<+U.*:IU')I)W6_D%T?05%<A\?/CO\+OV8_A!KOQX^-/B)M)\+>&[5;C6
M-12RFN#!&TBQ@^7"CR/\SJ,*I/-?)/\ Q$@?\$>/^CIKO_P@-<_^0ZJ%&M55
MX1;]$*Z1]RT5Y]^TO^U)\$/V0?@O?_M!_M ^+WT3PGIDELE[J<>FW%T8VGE2
M&(>5;H\AR[J.%.,Y. ":\6_9I_X+5_\ !-W]KWXT:1^S[^S_ /'NXUOQ9KJW
M#:9IDGA'5+42B"WDN)?WMQ;)&N(HG;YF&<8&20*4:564'.,6TNMM NCZJHHH
MK,9Y3^TG\6?%'PHU/P_?Z!-"T%PMT+VUN4!CF5?*QD]01N."#W[]*^?=*^(/
M[&_PG\>7_P 6?@7^S'X:T;XBZY'C4-:&GQHD1.0QA*]-Y)+",1[SRVXUH?\
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MU*W&CF_B@6)9S#]G\W=N59_];_K1NZ?+1AL53IRDYK2_,O5; TV>X?"GP/\
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L[;;NVV]VWJV%%%%:&04444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45750417481904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 17, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 17,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INNOVATE CORP.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">54-1708481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">295 Madison Ave<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">12th Fl<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">235-2691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001006837<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hchc_CommonStockParValue0001PerShareMember', window );">Common Stock, par value $0.001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VATE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hchc_PreferredStockPurchaseRightsMember', window );">Preferred Stock Purchase Rights</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Preferred Stock Purchase Rights<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NoTradingSymbolFlag', window );">No Trading Symbol Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoTradingSymbolFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a security having no trading symbol.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoTradingSymbolFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:trueItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hchc_CommonStockParValue0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hchc_CommonStockParValue0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hchc_PreferredStockPurchaseRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hchc_PreferredStockPurchaseRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MPZHFO0'^7RAE7QOIYE^^=]O[#U!+ P04    "  R0#5:GZ ;\+$"  #B#
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M#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
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MBBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @
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MX3]>?P%02P$"% ,4    "  R0#5:!T%-8H$   "Q    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( #) -5HZ@E)V[@
M "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( #) -5J97)PC$ 8  )PG   3              "  <P!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ ,D U6ONB3XS2!   QQ4  !@
M             ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( #) -5J?H!OPL0(  .(,   -              "  14-  !X;"]S
M='EL97,N>&UL4$L! A0#%     @ ,D U6I>*NQS     $P(   L
M     ( !\0\  %]R96QS+RYR96QS4$L! A0#%     @ ,D U6JK$(A8S 0
M(@(   \              ( !VA   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( #) -5HD'INBK0   /@!   :              "  3H2  !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( #) -5IED'F2&0$  ,\#
M   3              "  1\3  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0   )  D /@(  &D4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="hchc-20250117.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hc2.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="hchc-20250117.htm">hchc-20250117.htm</File>
    <File>hchc-20250117.xsd</File>
    <File>hchc-20250117_def.xml</File>
    <File>hchc-20250117_lab.xml</File>
    <File>hchc-20250117_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "hchc-20250117.htm": {
   "nsprefix": "hchc",
   "nsuri": "http://hc2.com/20250117",
   "dts": {
    "inline": {
     "local": [
      "hchc-20250117.htm"
     ]
    },
    "schema": {
     "local": [
      "hchc-20250117.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "hchc-20250117_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "hchc-20250117_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hchc-20250117_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 32,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 27
   },
   "report": {
    "R1": {
     "role": "http://hc2.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hchc-20250117.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hchc-20250117.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "hchc_CommonStockParValue0001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://hc2.com/20250117",
     "localname": "CommonStockParValue0001PerShareMember",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock, par value $0.001 per share",
        "label": "Common Stock, par value $0.001 per share [Member]",
        "documentation": "Common Stock, par value $0.001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "No Trading Symbol Flag",
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "hchc_PreferredStockPurchaseRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://hc2.com/20250117",
     "localname": "PreferredStockPurchaseRightsMember",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred Stock Purchase Rights",
        "label": "Preferred Stock Purchase Rights [Member]",
        "documentation": "Preferred Stock Purchase Rights"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://hc2.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001006837-25-000002-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001006837-25-000002-xbrl.zip
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MD -X'M<ENN)$/8ZHB4=9Z 0[@9 1L&&>B0+6UJ5TIH]B (\S-G@V,R0X?Y2
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MP=3+MKT1"5<HZ$9I0T.9>J5J_1#",EJ9RYQ J&!';>@#H6"O]7E9RX=1!O%
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MV$GS--\)W#'\UY-]K_Y_4$L#!!0    ( #) -5J39N):/ ,  !P+   1
M:&-H8RTR,#(U,#$Q-RYX<V3=5EM/VS 4?N=7>'F>FTNYI!4MTD!,2&Q#7#;>
MD&.?-!:)G=D.+?]^MM-02DNAFS1-RU-\SO<=GYN/?7@TJTKT $IS*49!W(L"
M!()*QL5D%-Q<G^(T.!KO[!Q^P/CVT^4Y.I&TJ4 8=*R &&!HRDV!3 'HAU3W
M_(&@BY*87*H*X[&G'<OZ4?%)85 2)7L=K-.J(=O;B]@@R3%)D@COQEF"L\$!
MX"CMYP=YEJ;)?OQQ,HP&^7Z4IBEF49K@W72_CPDY2'&TQQA-Z6Y&LL@;G>FA
MI@54!-G0A![.]"@HC*F'83B=3GO3?D^J29A$41S>?CF_\M!@CBVYN%]"SS)5
M=OA^Z-09T=#!"UK0)WA!DQZ55>BBC.+XH ,Y$WR#42ZT(8(^&65&8?-8@X[7
MDZP^='JW482C&"=Q@(@QBF>-@5.;^1/(25.:4="(GPTI><Z!V;*6X JW!'BF
M-D1-P'PE%>B:4'@]K/$.0B[)O*JE,DBL,'*B,^]IH_&$D-I1=P/4%N5<4F)\
MKSFTMG ?V%I."*71G00[26^F61"^Z<&F)*]S8RW%K7#'PTZ$XP3WX]_V8=$]
MV_G0\?[0A[5]\UI1WF+ZM7ZG&]Z0!MJ;R(>0 7]/0[R$NY\U+4"$D,;SG60N
MJVLN<MD*K,CE;]@E\1+R[ERN'/;Y:(@'@T'HM?9(>C)15,D2-H/#6LD:E.&@
MGP\*;Z!0D%NV'1>X.T=WM8*>]:2#K&RPW E.;7< ;8^PC_=\$5!GPM5D%&A;
MAQ+:%/W+\3/(MXW?4KC@_T7T)<FVC=Y2H-PR<$>\MGK$V2@XEO:B#Y"3W5R>
MK4QXOTF+Z8QT9A:)'T?^BQ%>/ 4P\JS#\"7VA95& _LFQO[_92O/R7/(!B(E
M)6W*[7G+O;.6-A=V.9M/E'!YI+3KI;'CAL[\=O5Y=I6^.Y95)<65D?3^@JCO
MI&S Y>T"U%5!%'R!*G/%()DVBE![%QO5V(YQT]-5ZEUDP4O;%*YS6K)_:@QM
M&W+)KGU7L$9Y-^VT;>Q.W#1N]5G)IAX%+9P;J.SUW\*?WAY#)BO"Q9E5.DN+
MB;L2Z(7M;E *6.MNHVCA^M.]^/3F*-_#_+LA^N*V]])XYQ=02P,$%     @
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M^<F@'B.\N]SE<.YOO*^@KC<OK;LLC366A#B4$"J=78M2S"BB)56H-XI#-,9
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M$:V?]PEA,Z(?[*NW+];O3)>_F_7MB_\#4$L#!!0    ( #) -5I#_EK@H@@
M ()%   5    :&-H8RTR,#(U,#$Q-U]P<F4N>&ULU9S9<MLZ$H;O\Q0:S^W
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M-AZSW ^0Z91'1U%X-$I>S._)"B%^?O7LYHOV3_LO.UX]^S]02P$"% ,4
M"  R0#5:0B&"6YP7   (;@  &P              @ $     83(P,C0Q,#(U
M."UK>&5X:&EB:70Y.3$N:'1M4$L! A0#%     @ ,D U6J?A'FN'$0  HHD
M !$              ( !U1<  &AC:&,M,C R-3 Q,3<N:'1M4$L! A0#%
M  @ ,D U6I-FXEH\ P  ' L  !$              ( !BRD  &AC:&,M,C R
M-3 Q,3<N>'-D4$L! A0#%     @ ,D U6O29_@_N"   *$(  !4
M     ( !]BP  &AC:&,M,C R-3 Q,3=?9&5F+GAM;%!+ 0(4 Q0    ( #)
M-5KE0!/?J T  &MW   5              "  1<V  !H8VAC+3(P,C4P,3$W
M7VQA8BYX;6Q02P$"% ,4    "  R0#5:0_Y:X*((  ""10  %0
M    @ 'R0P  :&-H8RTR,#(U,#$Q-U]P<F4N>&UL4$L%!@     &  8 D $
' ,=,      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>hchc-20250117_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:hchc="http://hc2.com/20250117"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hchc-20250117.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001006837</identifier>
        </entity>
        <period>
            <startDate>2025-01-17</startDate>
            <endDate>2025-01-17</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001006837</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hchc:CommonStockParValue0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-17</startDate>
            <endDate>2025-01-17</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001006837</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hchc:PreferredStockPurchaseRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-17</startDate>
            <endDate>2025-01-17</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-25">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-26">0001006837</dei:EntityCentralIndexKey>
    <dei:NoTradingSymbolFlag contextRef="c-3" id="f-27">true</dei:NoTradingSymbolFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-01-17</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">INNOVATE CORP.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-35210</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">54-1708481</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">295 Madison Ave</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">12th Fl</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">10017</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">10017</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">235-2691</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-16">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-2" id="f-19">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-2" id="f-20">VATE</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-2" id="f-21">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-3" id="f-22">Preferred Stock Purchase Rights</dei:Security12bTitle>
    <dei:SecurityExchangeName contextRef="c-3" id="f-23">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-24">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
